搜索
LAVA Therapeutics NV
LVTX添加自选
1.740USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
45.77M总市值
亏损市盈率 TTM
关于 LAVA Therapeutics NV 公司
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
LAVA Therapeutics NV简介
公司代码LVTX
公司名称LAVA Therapeutics NV
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
员工数量34
证券类型Ordinary Share
年结日Mar 25
公司地址Yalelaan 60
城市UTRECHT
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Netherlands
邮编3584 CM
电话31850163100
网址https://www.lavatherapeutics.com/
公司代码LVTX
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
LAVA Therapeutics NV公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
-100.00%
Mr. Edward F. Smith
Mr. Edward F. Smith
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
常见问题
LAVA Therapeutics NV的前五大股东是谁？
LAVA Therapeutics NV 的前五大股东如下：Dr. Kapil Dhingra, M.D.
有多少机构持有LAVA Therapeutics NV(LVTX)的股份？
截至2025Q4，共有49家机构持有LAVA Therapeutics NV的股份，合计持有的股份价值约为7.26M，占公司总股份的27.59%。与2025Q3相比，机构持股有所增加，增幅为-4778197.00。